Logo
B

BIND Therapeutics

4 employees

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Basic info

Industry

biotechnology research

Sectors

Clinical Trials
Biotechnology
Information Technology
Health Care
Medical

Date founded

2006

Funding rounds raised

Total raised

$26M

from 12 investors over 12 rounds

B

BIND Therapeutics raised $26M on February 13, 2012

Investors: JSC RUSNANO

B

BIND Therapeutics raised $12M on June 29, 2010

Investors: Endeavour Vision, Flagship Ventures, +ND Capital, ARCH Venture Partners and Polaris Partners

B

BIND Therapeutics raised $16M on November 27, 2007

Investors: ARCH Venture Partners, Polaris Partners, Flagship Ventures and +ND Capital

B

BIND Therapeutics raised $2.5M on February 7, 2007

Investors: Flagship Ventures and Polaris Partners

FAQ